Rockefeller Statement on FTC Privacy Report

WASHINGTON, D.C.—Chairman John D. (Jay) Rockefeller IV issued the following statement today after the Federal Trade Commission (FTC) unveiled its online privacy report with recommendations for the industry and policymakers:

Rockefeller, Cummings, and Harkin Investigate “Fake Pharmacies” Buying and Selling Shortage Drugs in the Gray Market

WASHINTON, D.C.—Today, Chairman John D. (Jay) Rockefeller IV, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Senator Tom Harkin, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, sent letters requesting documents from licensed pharmacies that are buying up drugs that are desperately needed to treat cancer and other illnesses and are in critically short supply, and are selling these drugs back into the gray market instead of providing them to patients who need them.

Senate Chairmen Join Cummings’ Investigation of “Gray Market” Drug Companies

WASHINGTON, D.C.—Chairman John D. (Jay) Rockefeller IV and Senator Tom Harkin, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, joined Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, in his investigation of “gray market” companies that trade in drugs in critically short supply.